UNSPSC 41202050: Reovirus serological reagents

In this classification, Reovirus serological reagents are devices used in test to identify specific Reovirus antibodies in serum. US FDA regulates Reovirus serological reagents under 21 CFR 866.3470 and under FDA product code GQB.

UNSPSC 41202050 Reovirus serological reagents is a Commodity code that does not match the recent state and local solicitations posted under it. The code nominally describes serological testing for reovirus, but the recent opportunities tagged to this code solicit HIV testing kits, HIV and Syphilis reagents, forensic laboratory analysis, offender drug testing services, pool maintenance, and clinical diagnostic laboratory services — none of which are reovirus-related. The mismatch suggests a classification error in the state and local procurement systems rather than active buying under the code's stated scope. No recent opportunities in the source solicitation block represent genuine reovirus serological reagent procurement.

The recent activity does not support a meaningful market characterization for this code. The state and local procurement systems show little or no relevant recent activity aligned with reovirus serological reagents, and the opportunities that appear under the code number address unrelated commodity and service categories. Business development professionals should verify the correct UNSPSC code alignment before pursuing opportunities listed under 41202050, as the posted solicitations do not reflect the code's nominal scope.